K. Ando

发表

Optimization of imidazole 5-lipoxygenase inhibitors and selection and synthesis of a development candidate.

T. Mano, R. Stevens, K. Ando, 2005, Chemical & pharmaceutical bulletin.

The SAR studies of novel CB2 selective agonists, benzimidazolone derivatives.

F. Ito, K. Omoto, K. Ando, 2008, Bioorganic & medicinal chemistry letters.

Structure-activity relationship study of novel NR2B-selective antagonists with arylamides to avoid reactive metabolites formation.

Kazunari Hattori, T. Honma, K. Ando, 2007, Bioorganic & medicinal chemistry letters.

THE ALKYLATION AND BASE-PROMOTED RING-OPENING REACTION OF 3-PHENYLSULFONYL-3-TRIMETHYLSILYLCYCLOBUTANOLS. A NEW METHOD FOR THE PREPARATION OF β-METHYLENE KETONES

K. Ando, T. Fujiwara, T. Takeda, 1983 .

Synthesis and SAR of heteroaryl-phenyl-substituted pyrazole derivatives as highly selective and potent canine COX-2 inhibitors.

S. Sakya, Jin Li, Hengmiao Cheng, 2006, Bioorganic & medicinal chemistry letters.

The reductive lithiation of thioacetals, α,α-bis(trimethylsilyl)-alkyl sulfides, and 2-alkyl-2-ethylthioalkanenitriles using tributylstannyllithium

K. Ando, A. Mamada, T. Fujiwara, 1985 .

Novel imidazole compounds as a new series of potent, orally active inhibitors of 5-lipoxygenase.

T. Mano, R. Stevens, K. Ando, 2003, Bioorganic & medicinal chemistry.

Reaction of α,α-Bis(trimethylsilyl)phenylthiomethyllithium with (Chloromethyl)oxiranes. Synthesis of 1-Alkyl-3-phenylthio-3-trimethylsilyl-1-trimethylsiloxycyclobutanes

K. Ando, S. Naito, T. Fujiwara, 1983 .

THE REACTION OF TRIBUTYLSTANNYLLITHIUM WITH 2-ETHOXY-3-ALKENENITRILES. A NEW METHOD FOR THE PREPARATION OF γ-ETHOXYALLYLSTANNANES AND DIENOL ETHERS

K. Ando, M. Inoue, T. Fujiwara, 1986 .

The sila-Pummerer rearrangement of 1-alkyl-3-phenylsulfinyl-3-trimethylsilylcyclobutanols. A new method for the preparation of 3-alkyl-2-cyclobutenones.

K. Ando, T. Tsuchida, T. Fujiwara, 1983 .

Discovery of novel and orally active NR2B-selective N-methyl-D-aspartate (NMDA) antagonists, pyridinol derivatives with reduced HERG binding affinity.

Kazunari Hattori, K. Ando, M. Kawai, 2007, Bioorganic & medicinal chemistry letters.

Cyclization Reactions of 1,2-Bis(2-cyanophenyl)propionitriles. II. Synthesis of 5-amino-4,7-dimethoxy-11H-indeno-[1,2-c]isoquinolin-11-one

K. Ando, T. Tokoroyama, T. Kubota, 1974 .

Cyclization Reactions of 2,3-Bis(2-cyanophenyl)propionitriles. III. Substituent Effect on the Carbanion Reactivies of the Propionitriles and Tautomerism of 5-Acetamido-11-cyanoindeno[1,2-c]isoquinolines

K. Ando, T. Tokoroyama, T. Kubota, 1980 .

CYCLIZATION REACTIONS OF 1,2-BIS(2-CYANOPHENYL)PROPIONITRILES PART 2, SYNTHESIS OF 5-AMINO-4,7-DIMETHOXY-11H-INDENO(1,2-C)ISOQUINOLIN-11-ON

K. Ando, T. Tokoroyama, T. Kubota, 1974 .

Cyclization Reactions of 1,2-Bis(2-cyanophenyl)propionitriles. I. Structure of the "Red Pigment" formed by the Base-catalyzed Cyclization of 1,2-Bis(2-cyano-3-methoxyphenyl)propionitrile in the Presence of Diethyl Carbonate

T. Kubota, K. Ando, Takashi Tokoro Yama, 1974 .

Identification of a novel 2-pyridyl-benzensulfonamide derivative, RQ-00203078, as a selective and orally active TRPM8 antagonist.

A. Yamada, K. Ando, K. Kawamura, 2014, Bioorganic & medicinal chemistry letters.

Discovery of (-)-6-[2-[4-(3-fluorophenyl)-4-hydroxy-1-piperidinyl]-1-hydroxyethyl]-3,4-dihydro-2(1H)-quinolinone--a potent NR2B-selective N-methyl D-aspartate (NMDA) antagonist for the treatment of pain.

Kazunari Hattori, Masaki Sudo, K. Ando, 2007, Bioorganic & medicinal chemistry letters.

Identification of a highly potent and selective CB2 agonist, RQ-00202730, for the treatment of irritable bowel syndrome.

Masaki Sudo, K. Ando, Y. Iwata, 2015, Bioorganic & medicinal chemistry letters.